Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Dbco-peg4-acetic-val-cit-pab | 98.2% | 855.97 | C45H57N7O10 | 50 MG
SDP

Catalog No. 5000202550
Encompass_Preferred

DBCO-PEG4-acetic-Val-Cit-PAB is a cleavable four-unit polyethylene glycol (PEG) linker that contains a dibenzocyclooctyne (DBCO) moiety and a Val-Cit-PAB protease-cleavable spacer. It is designed for use in antibody-drug conjugate assembly and for copper-free click chemistry (SPAAC) to attach azide-bearing payloads.

  • Cleavable Val-Cit-PAB dipeptide spacer for protease-triggered release.
  • Dbco group enables copper-free click conjugation (SPAAC) with azides.
  • Four-unit PEG spacer improves solubility and reduces steric hindrance.
  • High reported purity and defined molecular weight support reproducible conjugation chemistry.

Catalog No. 50-002-02550 Supplier Medchemexpress LLC Supplier No. HY13609850MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

DBCO-PEG4-acetic-Val-Cit-PAB is a cleavable four-unit polyethylene glycol (PEG) linker that contains a dibenzocyclooctyne (DBCO) moiety and a Val-Cit-PAB protease-cleavable spacer. It is designed for use in antibody-drug conjugate assembly and for copper-free click chemistry (SPAAC) to attach azide-bearing payloads.

  • Cleavable Val-Cit-PAB dipeptide spacer for protease-triggered release.
  • Dbco group enables copper-free click conjugation (SPAAC) with azides.
  • Four-unit PEG spacer improves solubility and reduces steric hindrance.
  • High reported purity and defined molecular weight support reproducible conjugation chemistry.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.